This report presents the available data for describing the current situation regarding HIV prevalence among sex workers, and the efforts being made across Europe and Central Asia towards HIV prevention among this population.
This rapid risk assessment addresses the public health risk associated with the early occurrence of a large number of West Nile virus infections in the EU/EEA and EU neighbouring countries in 2018.
The objective of this report is to systematically review the evidence on active case finding in prison settings, with a focus on the European Union (EU) and the European Economic Area (EEA) region.
The Ministry of Health in Bulgaria invited ECDC to prepare an assessment of the current national HIV programme and to review the STI and Hepatitis surveillance system. Following discussions between ECDC and representatives of the Bulgarian national programme, it was decided to split the assessment into two separate country missions.
This rapid risk assessment reviews the health risks related to communicable diseases in the context of the WorldPride festival in Madrid, from 23 June to 2 July 2017.
The recent floods in Bosnia and Herzegovina, Croatia, and Serbia caused substantial damage. Following the floods, there is a risk of increased transmission of vector-borne infections to the populations.
West Nile virus (WNV) is an emerging pathogen whose ecology and epidemiology extend across multiple interfaces. As the epidemiology and transmission cycle of WNV is complex, assessing the risk of WNV being transmitted to humans is not always straightforward. Therefore, the WNV risk assessment tool has been developed to provide operational guidance in support of the risk assessment process.
Within the context of the West Nile virus outbreaks, an ECDC mission was conducted at the end of the transmission season to support the Greek authorities regarding further response and prevention activities on West Nile virus infections.
Following an invitation from Greek authorities, a team of experts from ECDC, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the WHO Regional Office for Europe visited Greece in May 2012.